Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy

To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant women, we conducted an observational cohort study of pregnant women aged 16 years or older, with no history of SARS-CoV-2, who were vaccinated between 20 December 2020 and 3 June 2021. A total of 10,861 vaccinated pregna...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2021-10, Vol.27 (10), p.1693-1695
Hauptverfasser:	Dagan, Noa, Barda, Noam, Biron-Shental, Tal, Makov-Assif, Maya, Key, Calanit, Kohane, Isaac S., Hernán, Miguel A., Lipsitch, Marc, Hernandez-Diaz, Sonia, Reis, Ben Y., Balicer, Ran D.
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/255/2514 692/700/478/174 Analysis Biomedical and Life Sciences Biomedicine Brief Communication Cancer Research Confidence intervals Coronaviruses COVID-19 COVID-19 vaccines Health aspects Illnesses Infectious Diseases Messenger RNA Metabolic Diseases Molecular Medicine mRNA mRNA vaccines Neurosciences Observational studies Physiological aspects Pregnancy Pregnant women Severe acute respiratory syndrome coronavirus 2 Vaccine efficacy Vaccines Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!